- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Adicet Bio Inc (ACET)
Adicet Bio Inc stock price live, this page displays NASDAQ ACET stock exchange data. View the ACET premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Adicet Bio Inc real time stock price chart below.
What Is the Adicet Bio Inc Stock Price Today?
The Adicet Bio Inc stock price today is 7.610.
What Is the Stock Symbol for Adicet Bio Inc?
The stock ticker symbol for Adicet Bio Inc is ACET.
Is ACET the Same as $ACET?
$ACET is a common way to refer to the Adicet Bio Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Adicet Bio Inc Trade On?
Adicet Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Adicet Bio Inc a Good Stock to Buy?
Determining whether Adicet Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Adicet Bio Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACET quote. (ISIN: US0070022076)
What Is the Adicet Bio Inc Stock Price Today?
The Adicet Bio Inc stock price today is 7.610.
What Is the Stock Symbol for Adicet Bio Inc?
The stock ticker symbol for Adicet Bio Inc is ACET.
Is ACET the Same as $ACET?
$ACET is a common way to refer to the Adicet Bio Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Adicet Bio Inc Trade On?
Adicet Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Adicet Bio Inc a Good Stock to Buy?
Determining whether Adicet Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Adicet Bio Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACET quote. (ISIN: US0070022076)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.053
7.760
52 wk Range
6.407
17.438
ACET is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.0537.760
52 wk Range
6.40717.438
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ACET Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
61.500
Upside
+708.15%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Adicet Bio to implement 1-for-16 reverse stock split
- Investing.com
- Form 8K Adicet Bio Inc For: 29 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company’s lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin’s lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio Inc SWOT Analysis
Future Catalysts | Anticipate crucial clinical data readouts in 2025 for lupus treatments, potentially validating technology and attracting partnerships |
Market Challenges | Navigate the competitive CAR-T landscape as Adicet Bio aims to differentiate its approach in a crowded field of cell therapy developers |
Financial Footing | Strong cash position of $125 million extends runway into Q4 2026, supporting ongoing clinical trials despite absence of current revenue |
Pipeline Promise | Adicet Bio's innovative gamma-delta T cell therapies for autoimmune diseases and cancer show potential, with clinical trials underway for multiple indications |
Compare ACET to Peers and Sector
Metrics to compare | ACET | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACETPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −2.2x | −0.5x | |
PEG Ratio | −0.03 | −0.09 | 0.00 | |
Price / Book | 0.7x | 2.0x | 2.6x | |
Price / LTM Sales | - | 7.3x | 3.2x | |
Upside (Analyst Target) | - | 248.4% | 51.2% | |
Fair Value Upside | Unlock | 20.6% | 7.3% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 61.500
(+708.15% Upside)
Earnings
Latest Release
Mar 05, 2026
EPS / Forecast
-- / -0.1931
Revenue / Forecast
-- / 2.50M
People Also Watch
FAQ
What Is the Adicet Bio (ACET) Stock Price Today?
The Adicet Bio stock price today is 7.610 USD.
What Stock Exchange Does Adicet Bio Trade On?
Adicet Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Adicet Bio?
The stock symbol for Adicet Bio is "ACET."
What Is the Adicet Bio Market Cap?
As of today, Adicet Bio market cap is 78.320M USD.
What Is Adicet Bio's Earnings Per Share (TTM)?
The Adicet Bio EPS (TTM) is -20.177.
When Is the Next Adicet Bio Earnings Date?
Adicet Bio will release its next earnings report on Mar 05, 2026.
From a Technical Analysis Perspective, Is ACET a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Adicet Bio Stock Split?
Adicet Bio has split 2 times.
How Many Employees Does Adicet Bio Have?
Adicet Bio has 152 employees.
What is the current trading status of Adicet Bio (ACET)?
As of Mar 09, 2026, Adicet Bio (ACET) is trading at a price of 7.610 USD, with a previous close of 7.290 USD. The stock has fluctuated within a day range of 7.053 USD to 7.760 USD, while its 52-week range spans from 6.407 USD to 17.438 USD.
What Is Adicet Bio (ACET) Price Target According to Analysts?
The average 12-month price target for Adicet Bio is 61.500 USD, with a high estimate of 128 USD and a low estimate of 18 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +708.15% Upside potential.
What Is the ACET Premarket Price?
ACET's last pre-market stock price is 7.050 USD. The pre-market share volume is 120.000, and the stock has decreased by -0.240, or -3.290%.
What Is the ACET After Hours Price?
ACET's last after hours stock price is 7.700 USD, the stock has decreased by 0.090, or 1.180%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.